Dynamic Medical Technologies Inc.(TW:4138)
NT$54.20+0.40 (+0.74%)
TW:4138
Dynamic Medical Technologies Inc. financials statements
NT$54.20
At close:+0.40 (+0.74%)
Dynamic Medical Technologies Inc. (4138) Ratios
Dynamic Medical Technologies Inc. Ratios
TW:4138's free cash flow for Q2 2026 was NT$57.00M. For the 2026 fiscal year, TW:4138's free cash flow was decreased by NT$-12.74M and operating cash flow was NT$69.74M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.16 | 2.19 | 1.94 | 1.98 | 2.50 |
| Quick Ratio | 1.84 | 1.89 | 1.67 | 1.70 | 2.24 |
| Cash Ratio | 0.83 | 0.84 | 0.86 | 0.78 | 1.24 |
| Solvency Ratio | 0.24 | 0.31 | 0.26 | 0.22 | 0.27 |
| Operating Cash Flow Ratio | 0.36 | 0.26 | 0.33 | 0.32 | 0.42 |
| Short-Term Operating Cash Flow Coverage | 111.01 | 0.00 | 3.61 | -0.53 | -0.71 |
| Net Current Asset Value | NT$ 644.25M | NT$ 661.82M | NT$ 719.87M | NT$ 608.81M | NT$ 815.41M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.14 | 0.14 | 0.11 | 0.09 |
| Debt-to-Equity Ratio | 0.24 | 0.28 | 0.29 | 0.21 | 0.16 |
| Debt-to-Capital Ratio | 0.20 | 0.22 | 0.22 | 0.17 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.87 | 1.96 | 2.00 | 1.93 | 1.79 |
| Debt Service Coverage Ratio | 39.63 | 76.86 | 3.80 | -0.49 | -0.61 |
| Interest Coverage Ratio | 39.45 | 44.98 | 109.75 | 133.32 | 201.79 |
| Debt to Market Cap | 0.00 | 0.00 | 0.03 | -0.33 | -0.29 |
| Interest Debt Per Share | 8.73 | 11.89 | 12.24 | 8.70 | 6.33 |
| Net Debt to EBITDA | -0.93 | -0.64 | -1.08 | -1.33 | -2.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.09% | 40.01% | 37.84% | 35.03% | 34.49% |
| EBIT Margin | 13.70% | 18.77% | 18.81% | 13.90% | 16.99% |
| EBITDA Margin | 24.48% | 30.00% | 28.16% | 22.83% | 26.26% |
| Operating Profit Margin | 13.70% | 15.64% | 16.85% | 13.68% | 17.11% |
| Pretax Profit Margin | 15.71% | 18.42% | 18.66% | 13.79% | 16.91% |
| Net Profit Margin | 10.97% | 13.06% | 13.20% | 10.61% | 11.98% |
| Continuous Operations Profit Margin | 12.96% | 15.14% | 14.92% | 10.83% | 13.78% |
| Net Income Per EBT | 69.81% | 70.91% | 70.74% | 76.96% | 70.88% |
| EBT Per EBIT | 114.65% | 117.78% | 110.70% | 100.86% | 98.78% |
| Return on Assets (ROA) | 4.86% | 6.84% | 6.84% | 5.11% | 5.36% |
| Return on Equity (ROE) | 9.11% | 13.37% | 13.69% | 9.88% | 9.60% |
| Return on Capital Employed (ROCE) | 8.42% | 11.52% | 13.44% | 9.79% | 10.72% |
| Return on Invested Capital (ROIC) | 6.68% | 9.13% | 9.92% | 10.38% | 11.08% |
| Return on Tangible Assets | 4.87% | 6.85% | 6.85% | 5.12% | 5.37% |
| Earnings Yield | 5.35% | 6.74% | 5.87% | 8.67% | 9.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.76 | 7.39 | 8.06 | 7.04 | 7.70 |
| Payables Turnover | 13.39 | 19.93 | 37.82 | 13.10 | 10.94 |
| Inventory Turnover | 2.78 | 3.59 | 3.44 | 3.40 | 3.96 |
| Fixed Asset Turnover | 3.68 | 3.42 | 2.79 | 2.62 | 3.02 |
| Asset Turnover | 0.44 | 0.52 | 0.52 | 0.48 | 0.45 |
| Working Capital Turnover Ratio | 1.36 | 1.53 | 1.70 | 1.40 | 1.05 |
| Cash Conversion Cycle | 167.45 | 132.89 | 141.86 | 131.37 | 106.29 |
| Days of Sales Outstanding | 63.36 | 49.42 | 45.30 | 51.85 | 47.41 |
| Days of Inventory Outstanding | 131.35 | 101.78 | 106.22 | 107.38 | 92.24 |
| Days of Payables Outstanding | 27.26 | 18.31 | 9.65 | 27.86 | 33.35 |
| Operating Cycle | 194.71 | 151.21 | 151.51 | 159.22 | 139.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.56 | 6.17 | 9.94 | 8.39 | 8.41 |
| Free Cash Flow Per Share | 5.47 | 3.49 | 7.96 | 4.92 | 7.13 |
| Dividend Paid and CapEx Coverage Ratio | 1.53 | 0.70 | 2.17 | 1.23 | 1.88 |
| Capital Expenditure Coverage Ratio | 5.98 | 2.30 | 5.03 | 2.41 | 6.56 |
| Operating Cash Flow Coverage Ratio | 0.76 | 0.53 | 0.82 | 0.97 | 1.33 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.14 | 0.23 | 0.21 | 0.27 |
| Free Cash Flow Yield | 9.08% | 4.15% | 8.07% | 10.26% | 17.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.80 | 14.77 | 17.04 | 11.55 | 10.71 |
| Price-to-Sales (P/S) Ratio | 2.05 | 1.94 | 2.25 | 1.22 | 1.29 |
| Price-to-Book (P/B) Ratio | 1.70 | 1.98 | 2.33 | 1.14 | 1.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.01 | 24.07 | 12.39 | 9.75 | 5.62 |
| Price-to-Operating Cash Flow Ratio | 9.17 | 13.59 | 9.93 | 5.71 | 4.76 |
| Price-to-Earnings Growth (PEG) Ratio | -0.48 | -7.78 | 0.43 | 1.05 | 1.71 |
| Enterprise Value Multiple | 7.44 | 5.82 | 6.91 | 4.03 | 2.65 |
| Enterprise Value | 2.52B | 2.75B | 3.10B | 1.19B | 716.44M |
| EV to EBITDA | 7.44 | 5.82 | 6.91 | 4.03 | 2.65 |
| EV to Sales | 1.82 | 1.75 | 1.95 | 0.92 | 0.70 |
| EV to Free Cash Flow | 9.79 | 21.70 | 10.72 | 7.32 | 3.04 |
| EV to Operating Cash Flow | 8.15 | 12.25 | 8.59 | 4.29 | 2.58 |
| Tangible Book Value Per Share | 40.03 | 48.36 | 46.78 | 46.98 | 44.50 |
| Shareholders’ Equity Per Share | 35.37 | 42.32 | 42.29 | 42.05 | 38.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.18 | 0.20 | 0.21 | 0.18 |
| Revenue Per Share | 29.39 | 43.33 | 43.87 | 39.14 | 31.16 |
| Net Income Per Share | 3.22 | 5.66 | 5.79 | 4.15 | 3.73 |
| Tax Burden | 0.70 | 0.71 | 0.71 | 0.77 | 0.71 |
| Interest Burden | 1.15 | 0.98 | 0.99 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.31 | 0.24 | 0.21 | 0.23 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.04 | 0.77 | 1.21 | 1.55 | 1.60 |
Currency in TWD
